devil facial tumour
Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease
22
The ecology and epidemiology of devil facial tumour disease
240
Identification of candidate genes for devil facial tumour disease tumourigenesis
12
Tasman PCR: A genetic diagnostic assay for Tasmanian devil facial tumour diseases
10
Biomarker discovery for pre clinical diagnosis of Tasmanian devil facial tumour disease
201
Gomesin peptides prevent proliferation and lead to the cell death of devil facial tumour disease cells
11
Gomesin peptides prevent proliferation and lead to the cell death of devil facial tumour disease cells
11
Spatial analysis of Tasmanian Devil facial tumour disease
62
Global DNA Methylation patterns on marsupial and devil facial tumour chromosomes
11
ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)
25
Manipulating the immune response of Tasmanian Devils to target Devil Facial Tumour Disease
244
Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils
14
Immune recognition of devil facial tumour disease by the Tasmanian devil
221
The newly arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer
18
Toll like receptors in the endangered Tasmanian devil and devil facial tumour disease
314
Devil Facial Tumour Disease: In vivo studies in mice
282
Untangling the model muddle: Empirical tumour growth in Tasmanian devil facial tumour disease
7
Spatial analysis of Tasmanian Devil facial tumour disease
39
Population and disease modelling in the Tasmanian devil
114
Redefining the role of tumour necrosis factor in macrophage differentiation and effector function in bacterial and tumour defences
157